Summary Emerging SARS-CoV-2 sub-lineages like XBB. 1.5, XBB. 1.16, EG. 5, HK. 3 (FLip),
and XBB. 2.3 and the variant BA. 2.86 have recently been identified. Understanding the …

Abstract Anti–SARS-CoV-2 vaccination has saved millions of lives in the past few years. To
maintain a high level of protection, particularly in at-risk populations, booster doses are …

Since the SARS-CoV-2 Omicron virus has gained dominance worldwide, its continual
evolution with unpredictable mutations and patterns has revoked all authorized …

Several studies have suggested the imprinting of SARS-CoV-2 immunity by original immune
challenge without addressing the formation of the de novo response to successive antigen …

The emergence of novel Omicron subvariants has raised concerns regarding the efficacy of
immunity induced by prior Omicron subvariants breakthrough infection (BTI) or reinfection …

Introduction This study sought to elucidate the long-term antibody responses to the Moderna
mRNA-1273 COVID-19 vaccine within a Ugandan cohort, aiming to contribute to the sparse …

In the present study, Pušnik et al. investigated whether the XBB. 1.5-adapted booster can
overcome the persistent imprinting of SARS-CoV-2 immunity by wild-type based vaccines …

Most of vaccinees and COVID-19 convalescents can build effective anti-SARS-CoV-2
humoral immunity, which helps preventing infection and alleviating symptoms. However …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) studies usually rely on
cross-sectional data of large cohorts but limited repeated samples, overlooking significant …

Cancer patients (CPs), being immunosuppressed due to the treatment received or to the
disease itself, are more susceptible to infections and their potential complications, showing …